MyJournals Home  

RSS FeedsMarine Drugs, Vol. 15, Pages 189: Development of a Dunaliella tertiolecta Strain with Increased Zeaxanthin Content Using Random Mutagenesis (Marine Drugs)

 
 

21 june 2017 15:31:54

 
Marine Drugs, Vol. 15, Pages 189: Development of a Dunaliella tertiolecta Strain with Increased Zeaxanthin Content Using Random Mutagenesis (Marine Drugs)
 


Zeaxanthin is a xanthophyll pigment that is regarded as one of the best carotenoids for the prevention and treatment of degenerative diseases. In the worldwide natural products market, consumers prefer pigments that have been produced from biological sources. In this study, a Dunaliella tertiolecta strain that has 10-15% higher cellular zeaxanthin content than the parent strain (zea1), was obtained by random mutagenesis using ethyl methanesulfonate (EMS) as a mutagen. This mutant, mp3, was grown under various salinities and light intensities to optimize culture conditions for zeaxanthin production. The highest cellular zeaxanthin content was observed at 1.5 M NaCl and 65-85 ?mol photons·m-2·s-1, and the highest daily zeaxanthin productivity was observed at 0.6 M NaCl and 140-160 ?mol photons·m-2·s-1. The maximal yield of zeaxanthin from mp3 in fed-batch culture was 8 mg·L-1, which was obtained at 0.6 M NaCl and 140-160 ?mol photons·m-2·s-1. These results suggest that random mutagenesis with EMS is useful for generating D. tertiolecta strains with increased zeaxanthin content, and also suggest optimal culture conditions for the enhancement of biomass and zeaxanthin production by the zeaxanthin accumulating mutant strains.


 
155 viewsCategory: Biochemistry, Molecular Biology, Pharmacology
 
Marine Drugs, Vol. 15, Pages 188: Effects of Tetrodotoxin in Mouse Models of Visceral Pain (Marine Drugs)
Marine Drugs, Vol. 15, Pages 193: Fucoidan Does Not Exert Anti-Tumorigenic Effects on Uveal Melanoma Cell Lines (Marine Drugs)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten